sunitinib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
sunitinib
Apr 28, 2024, 12:38 |
Insight
Piotr Wysocki: Combined treatment (TKI+ICI) does not benefit favorable-risk mRCC patients
Piotr Wysocki recently shared on LinkedIn: "For several years, combined therapy based on the administration of…
Apr 26, 2024, 15:34 |
Insight
A Case Study of Metastatic Paraganglioma with Álvaro Lopes de Oliveira
Álvaro Lopes de Oliveira, Oncology Resident at A.C. Camargo Cancer Center, shared a thread on…
Apr 25, 2024, 00:51 |
Insight
New Paper Alert! Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Nivolumab plus Cabozantinib Maintains Long-Term Survival Benefit in Advanced Renal Cell Carcinoma Authors: T. Powles,…
Apr 22, 2024, 15:26 |
Blog
Olubukola Ayodele: Attending the IKCS Europe 2024 conference in the picturesque seaside town of Sitges
Olubukola Ayodele, Consultant Medical Oncologist at Leicester Cancer Research Centre, shared on LinkedIn: "I'm currently attending…
Apr 14, 2024, 10:45 |
Drugs
Final pre-spectified overall survival analysis of CLEAR, a phase III study - summarized by Yuksel Urun
Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…
Apr 14, 2024, 03:52 |
Drugs
Piotr Wysocki: CLEAR trial – another study demonstrating that Immunotherapy and TKI combination should not be routinely recommended to favorable-risk RCC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 10, 2024, 05:06 |
Insight
Toni Choueiri: The Renee Saliby kidney cancer biomarker paper in Cancer Cell is online with a detailed tweetorial
Toni Choueiri shared a post by Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
All:
8
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube